abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to compounds specified in cl. 1, and also to a pharmaceutical composition possessing binding activity with respect to Bcl proteins, to applying the declared compounds for preparing a drug for treating cancer and for treating a bcl-mediated disorder. n EFFECT: use of the compounds as Bcl protein inhibitors. n 18 cl, 2 tbl, 41 ex |